An apparatus for controlling the flow of urine in a urethra of a patient is provided, comprising an implantable adjustable constriction device for constricting the urethra to influence the flow in the urinary tract, a control device for controlling the constriction device, wherein the control device is configured to control the constriction device to constrict the urethra or to release a constriction of the urethra, and an operation device for operating the constriction device. The apparatus further comprises an energy source for supplying energy for the operation device, wherein the control device comprises a temperature sensor configured to sense a temperature of the apparatus or a temperature of the patient.

An apparatus for controlling a flow of urine in a urethra of a patient is disclosed, comprising an implantable constriction device for constricting the urethra to influence the flow in the urinary tract. The constriction device comprises a plurality of constriction elements configured to be arranged at different locations along the flow direction of the urethra, wherein each constriction element is configured to at least partly encircle the urethra and to be operable so as to change a constriction of the urethra. The apparatus further comprises an operation device configured to operate the constriction elements.

An apparatus for controlling a flow of urine in a urethra of a patient is provided, comprising an implantable constriction device for constricting the urethra to influence the flow in the urinary tract. The constriction device comprises a plurality of clamping elements configured to be arranged in a common plane intersecting the urethra and to be radially movable towards and away from a central axis of the urethra to change a constriction of the urethra. The apparatus further comprises an operation device configured to operate the movement of the clamping elements, an implantable motor configured to operate the operation device, and a gear box configured to transfer a force generated by the motor into a force operating the operation device.

An apparatus for controlling the flow of urine in a urethra of a patient is provided, comprising an implantable adjustable constriction device for constricting the urethra to influence the flow in the urinary tract, an operation device for operating the constriction device, a control device for controlling the operation device, and an energy source for supplying energy to the operation device. The control device is configured to determine the current state of the energy source, and connected to an internal signal transmitter configured to transmit information related to the current state of the energy source.

The present invention relates to method for implanting a medical device for controlling a flow of fluid in a lumen formed by a tissue wall of a patient's urethra. The method is performed by: cutting the skin of the patient, inserting a dissecting tool and dissecting an area of at least one portion of the tissue wall of the urethra, placing an adjustable constriction device in the dissected area in operative engagement with the urethra, placing an operation device configured to operate the adjustable constriction device to control the flow of urine in the urethra in the patient's body, placing a sensor configured to sense a temperature of the medical device in the patient's body, and placing a control unit in the patient's body configured to control the operation device based on information from the sensor.

Provided is a system and method for cavernosal neuromodulation as directed by a wireless remote controller and power supply. The system including: an implantable lead having at least one electrode structured and arranged to be disposed proximate to the cavernous nerve in a penis; a portable power supply; and a controller having wireless communication electronics and control circuitry associated with the wireless communication electronics structured and arranged to wirelessly couple the power supply to the at least one electrode, the controller further structured and arranged to permit a user to select at least one instruction set for the at least electrode. The controller and power supply may be provided by a control ring. An associated method of use is also provided.

An in-vitro method for stimulating the gene expression of at least one of XOXA10, LIF, ITGB3, XOXA11 and ITGAV genes in endometrial cells comprising applying on such endometrial cells electric current waves having a sinusoidal waveform with a fundamental frequency higher than 2 MHz, preferably of about 4 MHz, for a predefined amount of time.

A system for electrical stimulation of nerves of a living being, including a pulse generator configured to provide a sequence of electrical pulses to at least one electrode that are maintained in close proximity to the nerve of interest with the use of a feature to secure the electrode to the skin or tissue of the living being.

A submucosa treating apparatus according to an exemplary embodiment of the present invention includes: a probe that is capable of approaching mucosa of a treatment field; an electrode that is provided in the probe, and applies an electrical signal to blood vessels of submucosa; and a guide where the probe is movably accommodated, and a guide where the probe is movably accommodated, and guiding a position of the electrode with respect to the mucosa.

The present invention relates to a preoperative test method, to an implantation system (20) and to an implantation method for implanting a neuroprosthesis in the area of the pubic bone (31), wherein implantation is ultimately simplified and made more effective directly or indirectly by the subject-matters of the invention.